Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

fludarabine phosphate 47Peripheral Blood Stem Cell Transplantation 39Cyclophosphamide 39Busulfan 37Tacrolimus 33Mycophenolic Acid 29Methotrexate 26Cytarabine 25Cyclosporine 25Whole-Body Irradiation 24Antilymphocyte Serum 23Radiotherapy 16Etoposide 16Filgrastim 15Methylprednisolone 11Melphalan 11Transplantation 9Cord Blood Stem Cell Transplantation 9Idarubicin 8sargramostim 7Sirolimus 7Mitoxantrone 7merphos 6Thiotepa 6Granulocyte Colony-Stimulating Factor 6Flow Cytometry 6Alemtuzumab 6fludarabine 5aldesleukin 5Gemtuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Congenital Abnormalities × choline magnesium trisalicylate × Clear all
NCT02144675 2021-08-24

Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Rutgers, The State University of New Jersey

Phase 2 Completed
27 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡